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CASE REPORTS
Vertebral artery stent graft for a chronic
symptomatic vertebrojugular arteriovenous fistula
Hardev Ramandeep Singh Girn, MBBS, MRCS,a Simon J. McPherson, FRCR,b and
Charlotte Allan, MBBS,a West Yorkshire, United Kingdom
A patient with a chronic, symptomatic V2 segment vertebrojugular fistula was successfully treated with a vertebral artery
stent graft, with immediate tinnitus resolution. No early or late complications were observed, and at 45 months of
follow-up, the patient remains asymptomatic with a patent stent graft. The existing literature on stent graft treatment of
vertebrojugular fistula is reviewed. (J Vasc Surg 2009;49:1570-3.)An arteriovenous fistula (AVF) is an uncommon, but
recognized, complication of internal jugular vein (IJV)
catheterization and usually involves the carotid artery or
one of its branches; a vertebrojugular fistula (VJF) is rarer
still. Surgical ligation and endovascular coil embolization
have been used for the treatment of iatrogenic fistulas
between the vertebral artery (VA) and IJV. Coil emboliza-
tion sacrifices the VA and has the potential to cause verte-
brobasilar ischemia or infarction. Stents and stent grafts
have been sporadically used in nonatherosclerotic lesions of
the vertebrobasilar circulation. We identified five single-
case reports of the use of stent grafts in treatment of acute
and chronic VJF published in English1-5 (Table). This
report presents our experience of using a stent graft to
occlude a chronic VJF and reviews those previous reports.
CASE REPORT
40-year-old woman, who had previously had a right mastectomy
for breast carcinoma, woke up with headache and severe pulsatile
tinnitus after a breast reconstruction procedure. Ultrasound-guided
central venous catheter placement in the right IJV was attempted by
an anesthetist intraoperatively, but was abandoned after an arterial
puncture. The records do not state whether there was an attempt
to advance a central catheter or whether a needle puncture alone
was made. Despite the onset of symptoms coinciding with the
operative procedure, a definitive diagnosis was not made until 8
months after the procedure, when the patient complained of
imbalance and was referred to a neurologist. A palpable thrill and a
continuous audible bruit on auscultation were present on the right
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1570side of the neck, but the result of the neurologic examination was
normal.
A diagnostic four-vessel cerebral angiogram confirmed a fistula at
the base of the right neck involving the anterior wall of the V2
segment of the right VA (Fig). The left VA was marginally dominant.
The carotid circulationwas normal. Therewas no retrograde flow into
the fistula or the leftVAon either carotid injection.Thefistulationwas
initially from the right VA into the paravertebral venous plexus and
thence into the right IJV.
The treatment options and their risks and benefits were discussed
with the patient. The risks of VA thrombosis, stenosis, or emboliza-
tion were specifically discussed. Informed consent was obtained.
The VA had dilated proximal to the VJF, measuring 5.5 mm
pre-VJF and 3 mm post-VJF. Under local anesthesia through a
right common femoral puncture, a 4F sheath was placed. The right
subclavian artery was selectively catheterized, and an 8F 90-cm-
long flexible sheath (Arrow-flex PSI set, Arrow International,
Reading, Pa) was placed in the brachiocephalic artery over an
0.035-inch  180-cm, 6-cm floppy-tip Amplatz wire (Boston
Scientific Corp, Natick, Mass). The right VA was then selectively
catheterized with a vertebral 4F catheter and the long sheath ad-
vanced into the proximal right VA over a Platinum Plus ST wire
(Boston Scientific Corp, Meditech). A 6-mm  25-mm Viabahn
stent graft (W. L. Gore&Assoc, Flagstaff, Ariz) was placed across the
fistula through the sheath. The sheath was withdrawn, and the stent
graft was deployed after a check angiogram confirmed its position.
Systemic heparinization (5000 U bolus) was used. The proce-
dure only lasted 25minutes, so the level of anticoagulation was not
monitored. The patient had received clopidogrel and low-dose
aspirin for 1 week preoperatively. After deployment of the stent
graft (Fig), the AVF was occluded, and the patient’s tinnitus
immediately ceased. Clopidogrel and aspirin were continued for 6
months after the procedure. Indefinite low-dose aspirin has been
advised.
Ultrasound follow-up out to 45 months after the procedure
has demonstrated continued stent graft patency, with no flow
disturbance and normal VA flow distal to the stent graft. On
formal neurologic review, the patient remains asymptomatic.
s inser
sten
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 6 Girn et al 1571DISCUSSION
The risk of arterial puncture during percutaneous IJV
puncture is markedly reduced when ultrasound guidance is
used. Even if it does occur, development of an AVF is a rare
complication and more commonly involves the carotid
Table. Previously reported cases and the current case of v
First
author Etiology
Indication for
treatment
Tim
and
Ruckert1 Iatrogenic (IJV
catheterization)
Tinnitus 36 (
Gonzalez3 Iatrogenic (IJV
catheterization)
Tinnitus
Amar2 Stab injury to the
neck
Prevent possible stroke
from distal
embolization and
spinal cord damage
from vertebral
venous plexus
pressurization
0 (
Felber4 V2 post-op (no details
available)
Not recorded N
Saket5,a Vascular injury during
ascending aortic
dissection repair
High-output cardiac
failure
N
Current
case
Iatrogenic (IJV
catheterization)
Tinnitus 8 (
IJV, Internal jugular vein; US, ultrasound.
aAll devices inserted via a femoral route except that of Saket et al, which wa
Fig. A, Angiogram showing vertebro-jugular fistula on t
B, Resolution of the fistula following deployment of theartery. Iatrogenic injury resulting in a VJF is rare. Penetrat-ing neck trauma is the more commonly reported cause of a
VJF.6,7 However, amongst the five previously reported
cases of stent graft repair of a VJF, and the patient presented
here, the etiology was iatrogenic in five of six patients, with
only one penetrating injury reported (Table). This may
rojugular fistulas treated with stent grafts
resentation
ent (mon)
Stent graft used
(mm) Follow-up Complication
treatment) Jostent coronary,
4  20
15 mon; US at 4
months,
unspecified
“examination”
at 15 mon
None
3 Wallgraft, 6  20 9 mon (clinical) None
ency) Wallgraft, 6  20 6 wk (patient
refused further
follow-up)
None
ecorded Jostent coronary,
4  19
14 mon (patent
with no
stenosis;
imaging
method not
recorded
None
ecorded Jostent coronary,
2.7  20
16 mon clinical;
angiography
at 14 mon
None
reatment) Viabahn, 6  25 45 mon (US and
neurologist)
None
ted via ipsilateral arm artery access.
ht side with pre-fistula dilatation of the vertebral artery.
t graft.erteb
e to p
treatm
41 to
emerg
ot r
ot r
9 to the rigreflect the more chronic nature of these VJFs, which may
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than acute intervention. Until recently, appropriately sized
stent grafts would not have been widely available off-the-
shelf for acute cases.
Patients with a VJF may be asymptomatic. Tinnitus is
the most common presentation (Table); rarely, patients
can present with high-output cardiac failure. Our patient
experienced debilitating tinnitus without any signs of
cardiac failure. She also experienced intermittent balance
disturbance, which resolved immediately after the inter-
vention. Results of the preprocedural head CT and
neurologic examination were normal. The balance dis-
turbance was hypothesized to have been due to vertebro-
basilar ischemia (steal effect) secondary to the VJF,
although no retrograde flow was found in the right VA or
left VA to support this.
The treatment options for a symptomatic VA VJF are
either surgical ligation of the fistula or an endovascular
approach. One of the endovascular options is occlusion
of the VA, and the use of detachable balloons, coils, and
hooded stent grafts have all been recorded. This carries
the risk of posterior fossa ischemic symptoms acutely if
the contralateral VA is deficient or later in life if the
remaining VA becomes compromised by other disease
processes such as atherosclerosis. Endovascular stent
graft deployment in the VA is the option we chose.7,8
Like surgery, stent grafting of the VA aims to preserve
the ipsilateral supply to the basilar artery. The risk of
thromboembolization and in-stent stenosis associated
with a stent graft must be considered and discussed with
the patient. Extrapolation from cardiac experience sug-
gests aggressive antiplatelet therapy militates against
this.9
Alternative endovascular approaches include coil em-
bolization of the fistula track from either an arterial,
venous, or combined approach. Coil misplacement and
embolization could lead to posterior fossa infarction if
this happens on the arterial side. Coil migration on the
venous side could lead pulmonary embolization, likely
clinically insignificant, or possibly systemic embolization
if the patient has a patent foramen ovale. An uncovered
stent could be deployed in the VA and coiling performed
through the stent to “jail” any coils, but this would have
similar risks to stent grafting without definitely occlud-
ing the VJF. Transvenous coiling would have been diffi-
cult in this patient due to the connection by tortuous
paravertebral plexus radicles.
Stent graft occlusion of the venous side of an AVF has
been reported.10 This is effective where there is a short,
direct AVF. In our patient, occlusion of the connection to
the IJV with a jugular vein stent graft would have probably
failed because the paravertebral plexus could still preserve
patency of the AVF. Surgery of the VA is technically chal-
lenging but has proven long-term patency rates.
In a review of 369 consecutive surgical reconstructions
of the extracranial VA for mixed atherosclerotic and non-
atherosclerotic pathologies, Berguer et al11 reported a
stroke rate of 1.9% to4.1%with a 5-year patency rate of80%.Comparable results with similar stroke rates have also been
reproduced in the other surgical series.12 Additional rare
complications includeHorner syndrome, phrenic nerve paral-
ysis, laryngeal nerve injury, VII cranial nerve injury, and lymph
leakage.11-13 None of these complications were encountered
in the previously reported five cases of endovascular treatment
of VJF using a flow-preserving endoprosthesis in the VA
(Table).
The choice of stent graft is dictated by device availabil-
ity, the caliber of the VA proximal and distal to the fistula,
and the tortuosity, angulation, and patency of the access
route. In a chronic VJF, as in our patient, the prefistula
segment of VA may be dilatated due to the increased blood
flow. None of the previous five reported patients described
significant discrepancy in size in the pre-VJF and post-VJF
VA. In these circumstances, the stent graft treatment op-
tions are a self-expanding stent graft sized to the prefistula
VA or a balloon-expandable stent graft with initial dilata-
tion sized to the postfistula VA and then appropriately sized
flaring of the proximal stent graft with a larger balloon to
occlude the VJF.
There are negatives to both options. The under-
dilated portion of the self-expanding stent graft in the
distal segment may become crenulated, causing a degree
of stenosis or even failure to seal the VJF if retrograde
flow is present around the nonapposed portions of
the stent graft. A balloon-expandable stent graft requires
more instrumentation, with consequent risk of vessel
damage and embolic complications, and there is a risk of
dissecting or rupturing the VA if the larger proximal
balloon is not precisely positioned to avoid over-
dilatation of the postfistula VA. We chose a Viabahn
self-expanding stent graft for its lower radial force and
conformability.
Clear recording of the imaging follow-up to assess stent
graft patency has been variable in the previously reported
cases, with imaging recorded out to 14 months.4,5 Clinical
follow-up alone will not detect asymptomatic stent graft oc-
clusions, which, although not necessarily of clinical impor-
tance to the individual patient, may inform future practice if
occlusive changes are demonstrated. All reported patients
have been symptom-free,with no reintervention in the known
follow-up periods; however, reporting bias may have pre-
vented publication of patients with adverse outcomes. Our
literature search was limited to an Ovid-Medline search in
English, and cases might have been reported in other lan-
guages.
No periprocedural complications developed in our pa-
tient, and she remains symptom-free with a patent stent
graft noted on the most recent 45-month follow-up US
scan. Because the durability of these endoprostheses is
unknown, we plan indefinite yearly follow-up duplex scans
and neurologic review. There is no clear evidence or con-
sensus on the optimum antiplatelet regimen or its duration
in this setting. Advice on antiplatelet treatment is largely
extrapolated from coronary and carotid artery stenting
data. Long-term compliance with antiplatelet therapy
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CONCLUSION
Stent grafts are a useful addition to the conventional
therapeutic armamentarium for VJF, but the procedure
must be presumed to carry some risk of posterior circu-
lation stroke or transient ischemic attack. In addition,
the effect of mechanical stresses on the stent graft dura-
bility from neck movement is not yet known. With the
present level of evidence, indefinite follow-up at regular
intervals is recommended to detect device related com-
plications.
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